helioxanthin has been researched along with Mouth Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bau, DT; Hsieh, YL; Hsien, HH; Hsu, HH; Huang, CY; Kuo, WW; Lin, YM; Tu, CC; Velmurugan, BK; Viswanadha, VP | 1 |
1 other study(ies) available for helioxanthin and Mouth Neoplasms
Article | Year |
---|---|
Helioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arecoline; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase 2; Dinoprostone; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; G2 Phase Cell Cycle Checkpoints; Heterografts; Lignans; Male; MAP Kinase Signaling System; Mice, Nude; Mouth Neoplasms; Signal Transduction; Transcription Factor AP-1 | 2016 |